MX2012003892A - Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. - Google Patents

Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.

Info

Publication number
MX2012003892A
MX2012003892A MX2012003892A MX2012003892A MX2012003892A MX 2012003892 A MX2012003892 A MX 2012003892A MX 2012003892 A MX2012003892 A MX 2012003892A MX 2012003892 A MX2012003892 A MX 2012003892A MX 2012003892 A MX2012003892 A MX 2012003892A
Authority
MX
Mexico
Prior art keywords
agent
exacerbation
human knee
knee osteoarthritis
preventative
Prior art date
Application number
MX2012003892A
Other languages
English (en)
Other versions
MX339484B (es
Inventor
Tatsuhiko Kuroda
Toshinori Ishizuya
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of MX2012003892A publication Critical patent/MX2012003892A/es
Publication of MX339484B publication Critical patent/MX339484B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención tiene como objetivo proporcionar un medicamento que es extremadamente útil para prevenir y/o tratar y/o limitar la exacerbación de la osteoartritis de rodilla humana. Los medios para lograr esto son un medicamento caracterizado porque comprende una hormona paratiroidea (PTH) o un derivado de PTH como un ingrediente activo para prevenir y/o tratar y/o limitar la exacerbación de la osteoartritis de rodilla humana.
MX2012003892A 2009-11-18 2010-11-05 Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. MX339484B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26221409P 2009-11-18 2009-11-18
PCT/JP2010/069742 WO2011062073A1 (ja) 2009-11-18 2010-11-05 ヒト変形性膝関節症の予防剤および／または治療剤および／または増悪抑制剤

Publications (2)

Publication Number Publication Date
MX2012003892A true MX2012003892A (es) 2012-05-08
MX339484B MX339484B (es) 2016-05-27

Family

ID=44059554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003892A MX339484B (es) 2009-11-18 2010-11-05 Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.

Country Status (14)

Country Link
US (2) US20110172154A1 (es)
EP (1) EP2502632B1 (es)
JP (1) JP5969763B2 (es)
KR (1) KR101686271B1 (es)
CN (1) CN102686236A (es)
AU (1) AU2010320272B2 (es)
BR (1) BR112012002391A2 (es)
CA (1) CA2770340C (es)
ES (1) ES2616004T3 (es)
IL (1) IL217722B (es)
MX (1) MX339484B (es)
NZ (1) NZ598856A (es)
RU (1) RU2569754C2 (es)
WO (1) WO2011062073A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017006908A1 (ja) * 2015-07-07 2017-01-12 旭化成ファーマ株式会社 特発性大腿骨頭壊死症の発症予防及び／又は進行抑制剤
BR112018075613A2 (pt) * 2016-06-10 2019-04-09 Regulaxis peptídeos para o tratamento de osteoartrite
CN110520148A (zh) * 2017-02-01 2019-11-29 约翰霍普金斯大学 甲状旁腺激素与退行性椎间盘疾病的再生

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140924A (en) 1980-04-04 1981-11-04 Teijin Ltd Calcitonin pharmaceutical preparation
SE460638B (sv) 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
CA1188987A (en) 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
JPS60161924A (ja) 1984-02-01 1985-08-23 Fujisawa Pharmaceut Co Ltd 肺吸収用組成物
JPS63243033A (ja) 1987-03-31 1988-10-07 Toyo Jozo Co Ltd 経鼻投与組成物
JPS63316737A (ja) 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
JPH02111A (ja) 1987-08-03 1990-01-05 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド製剤
JPH01230530A (ja) 1987-11-21 1989-09-14 Toyo Jozo Co Ltd カルシトニン類経鼻投与用液剤組成物
JPH02104531A (ja) 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
JP2006137768A (ja) 1993-10-27 2006-06-01 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
JPH07238033A (ja) 1993-10-27 1995-09-12 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
JP3901761B2 (ja) 1995-02-20 2007-04-04 幸夫 加藤 変形性関節症および炎症性関節疾患治療剤
WO1996025944A1 (fr) * 1995-02-20 1996-08-29 Yukio Kato Remedes contre la polyarthrite rhumatoide et les affections articulaires inflammatoires
NZ523457A (en) 2000-06-30 2004-11-26 Daiichi Suntory Pharma Co Composition for stimulating bone formation comprising hPTH in which the acetic acid component is low enough for administration to the nasal mucosa
AU2003217243A1 (en) * 2003-01-24 2004-08-23 Thomas J. Gardella Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
JPWO2005102381A1 (ja) * 2004-04-26 2008-03-06 小野薬品工業株式会社 カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤
JP2006143603A (ja) * 2004-11-16 2006-06-08 Asahi Kasei Pharma Kk 骨疾患治療用医薬複合剤
US20090010940A1 (en) * 2005-09-06 2009-01-08 Paul Morley Parathyroid Hormone Analogues and Methods of Use
WO2010045229A2 (en) * 2008-10-13 2010-04-22 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
US8530420B2 (en) * 2008-12-16 2013-09-10 Kaohsiung Medical University Treatment of arthritis with parathyroid hormone
US8586533B2 (en) * 2008-12-16 2013-11-19 Kaohsiung Medical University Treatment of early-stage osteoarthritis
JPWO2011030774A1 (ja) * 2009-09-09 2013-02-07 旭化成ファーマ株式会社 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤

Also Published As

Publication number Publication date
EP2502632A1 (en) 2012-09-26
IL217722A0 (en) 2012-03-29
IL217722B (en) 2018-06-28
CA2770340A1 (en) 2011-05-26
CA2770340C (en) 2019-08-27
US20110172154A1 (en) 2011-07-14
MX339484B (es) 2016-05-27
AU2010320272A1 (en) 2012-04-12
JPWO2011062073A1 (ja) 2013-04-04
US20130012440A1 (en) 2013-01-10
RU2012125066A (ru) 2013-12-27
EP2502632B1 (en) 2016-12-28
KR20120116901A (ko) 2012-10-23
BR112012002391A2 (pt) 2016-06-07
KR101686271B1 (ko) 2016-12-13
WO2011062073A1 (ja) 2011-05-26
CN102686236A (zh) 2012-09-19
NZ598856A (en) 2013-10-25
ES2616004T3 (es) 2017-06-09
JP5969763B2 (ja) 2016-08-17
EP2502632A4 (en) 2013-04-03
RU2569754C2 (ru) 2015-11-27
AU2010320272B2 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
UA106634C2 (uk) Тверда фармацевтична дозована форма
PH12016500606A1 (en) Insulin preparations containing methionine
NZ603319A (en) Diabetes therapy
GB2491775A (en) Pulsatile drug release
MX2013013809A (es) Dispositivos expandibles con revestimiento de una composicion de paclitaxel.
PH12014501560A1 (en) Carbamate compounds and of making and using same
MX2012012438A (es) Formulaciones farmaceuticas que comprenden pioglitazona y linagliptina.
NZ602510A (en) Treatment of lupus nephritis using laquinimod
IN2014MN00933A (es)
MY191380A (en) Stabilized fixed dose drug composition having mometasone and olopatadine
MX335951B (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
EP3308785A3 (en) Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
JO3156B1 (ar) ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا
NZ598600A (en) Therapeutic agent for rhinitis
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
EP2572711A4 (en) ANTIMALARIAL MEDICINE THAT CONTAINS 5-AMINOLEVULINIC ACID OR A DERIVATIVE AS AN ACTIVE INGREDIENT
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
EP2168586A4 (en) ACTIVE AGENT, REMEDY, PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF PATIENTS WITH DENTAL SYNDROME
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MX2013013808A (es) Dispositivos expandibles con revestimiento de una composicion de rapamicina.
MX339484B (es) Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.
GB2446341A (en) Method and system for transdermal drug delivery
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
IN2014CN04222A (es)

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration